Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
David Cheng, Jac Kee Low, Warren Logge, et al.
Psychopharmacology (2014) Vol. 231, Iss. 15, pp. 3009-3017
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
Antioxidants (2019) Vol. 9, Iss. 1, pp. 21-21
Open Access | Times Cited: 627
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 536
Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 230
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 213
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Georgia Watt, Tim Karl
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 199
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Acta Biochimica et Biophysica Sinica (2017) Vol. 49, Iss. 10, pp. 853-866
Open Access | Times Cited: 184
Cannabidiol for neurodegenerative disorders: A comprehensive review
Sukanya Bhunia, Nagesh Kolishetti, Adriana Yndart, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 73
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 22
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Fernanda Fiel Peres, Alvaro C. Lima, Jaime E. C. Hallak, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 156
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Ashleigh L. Osborne, Nadia Solowij, Katrina Weston‐Green
Neuroscience & Biobehavioral Reviews (2016) Vol. 72, pp. 310-324
Open Access | Times Cited: 144
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders
Jonathan Lee, Leandro J. Bertoglio, Francisco Silveira Guimarães, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 19, pp. 3242-3256
Open Access | Times Cited: 132
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
Ashleigh L. Osborne, Nadia Solowij, Ilijana Babic, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 7, pp. 1447-1457
Open Access | Times Cited: 131
CB2 Receptor in Microglia: The Guardian of Self-Control
Joanna Agnieszka Komorowska‐Müller, Anne‐Caroline Schmöle
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 19-19
Open Access | Times Cited: 123
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Angélica Pupin Schiavon, Jéssica Mendes Bonato, Humberto Milani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 27-34
Closed Access | Times Cited: 123
Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
Miguel Á. Luján, Adriana Castro‐Zavala, Laia Alegre-Zurano, et al.
Neuropharmacology (2018) Vol. 143, pp. 163-175
Closed Access | Times Cited: 119
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings
Sonja Elsaid, Stefan Kloiber, Bernard Le Foll
Progress in molecular biology and translational science (2019), pp. 25-75
Closed Access | Times Cited: 119
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
Ian A. Clark, Bryce Vissel
Journal of Neuroinflammation (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 112
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
Shani Poleg, Pavel Golubchik, Daniel Offen, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 89, pp. 90-96
Closed Access | Times Cited: 106
Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
Rosaliana Libro, Francesca Diomede, Domenico Scionti, et al.
International Journal of Molecular Sciences (2016) Vol. 18, Iss. 1, pp. 26-26
Open Access | Times Cited: 97
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Marta Aymerich, Ester Aso, Miguel Angel Abellanas, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 67-84
Open Access | Times Cited: 95
Cannabinoid Regulation of Fear and Anxiety: an Update
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 95
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Constituents of Cannabis Sativa
Erin M. Rock, Linda A. Parker
Advances in experimental medicine and biology (2020), pp. 1-13
Closed Access | Times Cited: 79
Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease
David Schubert, Devin Kepchia, Zhibin Liang, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 11, pp. 7719-7730
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top